Functional Imaging in the Evaluation of Treatment Response in Multiple Myeloma: The Role of PET-CT and MRI
Bone disease is among the defining characteristics of symptomatic Multiple Myeloma (MM). Imaging techniques such as fluorodeoxyglucose positron emission tomography–computed tomography (FDG PET/CT) and magnetic resonance imaging (MRI) can identify plasma cell proliferation and quantify disease activi...
Main Authors: | Adele Santoni, Martina Simoncelli, Marta Franceschini, Sara Ciofini, Sara Fredducci, Federico Caroni, Vincenzo Sammartano, Monica Bocchia, Alessandro Gozzetti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/11/1885 |
Similar Items
-
Anti CD38 monoclonal antibodies for multiple myeloma treatment
by: Alessandro Gozzetti, et al.
Published: (2022-11-01) -
Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future
by: Alejandro Medina-Herrera, et al.
Published: (2023-07-01) -
Interest of Pet Imaging in Multiple Myeloma
by: Bastien Jamet, et al.
Published: (2019-04-01) -
Steps towards a Multiple Myeloma Cure?
by: Alessandro Gozzetti, et al.
Published: (2022-09-01) -
Minimal residual disease negativity by next‐generation flow in non‐CR myeloma patients
by: Sung‐Min Kim, et al.
Published: (2020-11-01)